Randomised Controlled TrialtaVNS

Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial

Kornum DS, Bertoli D, Kufaishi H, Wegeberg AM, Okdahl T, Mark EB, Høyer KL, Frøkjær JB, Brock B, Krogh K, et al.

Diabetologia · 2024

Key finding

Sixty-eight participants were randomised to the active group, while 77 were randomised to the sham group.

Condition
Gut Health
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
View on DOI

Cite this study

Kornum, D. S., Bertoli, D., Kufaishi, H., Wegeberg, A. M., Okdahl, T., Mark, E. B., Høyer, K. L., Frøkjær, J. B., Brock, B., Krogh, K., Hansen, C. S., Knop, F. K., Brock, C., & Drewes, A. M. (2024). Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial. Diabetologia, 67(6), 1122-1137. https://doi.org/10.1007/s00125-024-06129-0

Related studies in Gut Health

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.